AU6866291A - Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts - Google Patents

Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts

Info

Publication number
AU6866291A
AU6866291A AU68662/91A AU6866291A AU6866291A AU 6866291 A AU6866291 A AU 6866291A AU 68662/91 A AU68662/91 A AU 68662/91A AU 6866291 A AU6866291 A AU 6866291A AU 6866291 A AU6866291 A AU 6866291A
Authority
AU
Australia
Prior art keywords
mixtures
metal salts
active compounds
pharmacologically active
organic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68662/91A
Inventor
Larry M. Allen
Russell T. Jordan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abeona Therapeutics Inc
Original Assignee
Chemex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemex Pharmaceuticals Inc filed Critical Chemex Pharmaceuticals Inc
Publication of AU6866291A publication Critical patent/AU6866291A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU68662/91A 1986-11-19 1991-01-04 Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts Abandoned AU6866291A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU67794/87 1986-11-19
PCT/US1986/002547 WO1988003805A1 (en) 1986-11-19 1986-11-19 Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU67794/87A Division AU6779487A (en) 1986-11-19 1986-11-19 Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts

Publications (1)

Publication Number Publication Date
AU6866291A true AU6866291A (en) 1991-03-14

Family

ID=22195725

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68662/91A Abandoned AU6866291A (en) 1986-11-19 1991-01-04 Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts

Country Status (4)

Country Link
EP (1) EP0290442A4 (en)
JP (1) JPH01501791A (en)
AU (1) AU6866291A (en)
WO (1) WO1988003805A1 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012563A1 (en) * 1989-04-24 1990-11-01 Board Of Regents, The University Of Texas System Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue
US5248668A (en) * 1991-05-16 1993-09-28 Wintek Consulting Ltd. Use of purpurogallin and glycosides thereof in treating ischemia in mammals
WO1992020332A1 (en) * 1991-05-16 1992-11-26 Wu Tai Wing Pharmaceutical composition comprising purpurogallin useful as an antioxidant and cytoprotective agent
FR2686512B1 (en) * 1992-01-28 1995-06-30 Ir2M PHARMACEUTICAL COMPOSITIONS CONTAINING AS ACTIVE INGREDIENT COMBINATIONS OF VANADIUM AND / OR NIOBIUM WITH PYROCATECHOL DERIVATIVES.
WO1995005156A1 (en) * 1993-08-17 1995-02-23 Schering-Plough Healthcare Products, Inc. Compositions for treating corns, calluses and warts
AU698313B2 (en) * 1994-03-14 1998-10-29 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
GB9405046D0 (en) * 1994-03-15 1994-04-27 Unilever Plc Skin treatment composition
JPH0892157A (en) * 1994-05-02 1996-04-09 F Hoffmann La Roche Ag Purpurogallin derivative
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
FI980216A0 (en) * 1998-01-30 1998-01-30 Bene Pharma Oy Medicin Foer behandling av vaorfor
US7846919B2 (en) 1998-02-10 2010-12-07 Dermex Pharmaceuticals, Llc Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
AU1140500A (en) * 1998-10-20 2000-05-08 Chen-Kung Chou Therapeutic compounds and methods
US7033615B2 (en) 1999-07-09 2006-04-25 Cancer2 Inc. Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues
EP1200104A1 (en) * 1999-07-09 2002-05-02 Cancer2 Inc. Cadmium containing compositions
JP4570184B2 (en) * 1999-08-18 2010-10-27 卓二 田中 Antitumor agent
AU7958701A (en) * 2000-07-28 2002-02-13 Immupharm Aps Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
US6475526B1 (en) * 2001-06-05 2002-11-05 Jeffrey B. Smith Zinc containing compositions for anti-viral use
JP5362572B2 (en) * 2006-10-02 2013-12-11 エリモス ファーマシューティカルズ エルエルシー Tetra-O-substituted butane bridged modified NDGA derivatives, their synthesis and pharmaceutical use
CN102131766B (en) 2008-08-25 2013-12-11 杜邦电子聚合物公司 New propanoates and processes for preparing the same
BR112013003631B1 (en) 2010-08-18 2021-10-13 Samumed, Llc BETA- AND GAMMA-DICETONES AND GAMMA-HYDROXYCETONES AND PHARMACEUTICAL COMPOSITIONS INCLUDING THEM
US10857266B2 (en) 2012-08-15 2020-12-08 Mimedx Group, Inc. Reinforced placental tissue grafts and methods of making and using the same
US9943551B2 (en) 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
US9180145B2 (en) 2012-10-12 2015-11-10 Mimedx Group, Inc. Compositions and methods for recruiting and localizing stem cells
US9155799B2 (en) 2012-11-19 2015-10-13 Mimedx Group, Inc. Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent
US8946163B2 (en) 2012-11-19 2015-02-03 Mimedx Group, Inc. Cross-linked collagen comprising metallic anticancer agents
US9662355B2 (en) 2013-01-18 2017-05-30 Mimedx Group, Inc. Methods for treating cardiac conditions
US10206977B1 (en) 2013-01-18 2019-02-19 Mimedx Group, Inc. Isolated placental stem cell recruiting factors
KR102252567B1 (en) 2013-02-22 2021-05-17 사뮤메드, 엘엘씨 Gamma-diketones as wnt/beta-catenin signaling pathway activators
US10029030B2 (en) 2013-03-15 2018-07-24 Mimedx Group, Inc. Molded placental tissue compositions and methods of making and using the same
US10335433B2 (en) * 2013-04-10 2019-07-02 Mimedx Group, Inc. NDGA polymers and metal complexes thereof
US9446142B2 (en) 2013-05-28 2016-09-20 Mimedx Group, Inc. Polymer chelator conjugates
KR101580716B1 (en) * 2013-05-29 2015-12-30 숙명여자대학교산학협력단 Pharmaceutical compositions for prevention and treatment of cancer and menopausal symptom of women containing isolated compound from Larrea nitida or the pharmaceutically acceptable salts as an active ingredient
EP3038630B1 (en) 2013-08-30 2020-03-18 MIMEDX Group Inc. Micronized placental compositions comprising a chelator
EP3094336A4 (en) 2014-01-17 2018-02-14 MIMEDX Group Inc. Method for inducing angiogenesis
WO2016029021A1 (en) 2014-08-20 2016-02-25 Samumed, Llc Gamma-diketones for treatment and prevention of aging skin and wrinkles
US10617785B2 (en) 2014-08-28 2020-04-14 Mimedx Group, Inc. Collagen reinforced tissue grafts
CN114163411A (en) * 2021-11-16 2022-03-11 宁波大学 Preparation method of enantiomer pure dihydromyricetin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7760M (en) * 1968-11-22 1970-03-16
US3934034A (en) * 1972-08-21 1976-01-20 Sandoz, Inc. Hydroxy substituted diphenylalkyls for treatment of lipidemia
US4350707A (en) * 1976-02-05 1982-09-21 Research Corporation Inactivation of lipid containing viruses with butylated hydroxytoluene
US4084006A (en) * 1976-06-18 1978-04-11 Leach Byron E Method of using dialkylphenols an antiviral agents
DE2658307C2 (en) * 1976-12-22 1979-03-15 Klinge Pharma Gmbh & Co, 8000 Muenchen Di-O'-hydroxyphenyD-alkane compounds, process for their preparation and their use as medicaments
US4268517A (en) * 1979-08-30 1981-05-19 Continental Pharma Pharmaceutical composition and therapeutical method for treating degenerative affections of the articular cartilage
EP0037800B1 (en) * 1980-04-03 1987-08-12 Zyma SA Use of o-substituted derivatives of (+)-cyanidanol-3 as compounds with immunomodulative properties
US4880637A (en) * 1985-02-11 1989-11-14 Chemex Pharmaceuticals, Inc. Compositions of catecholic butanes with zinc
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
WO1988001509A1 (en) * 1986-08-25 1988-03-10 Chemex Pharmaceuticals, Inc. Pharmacologically active compositions of catecholic butanes with zinc

Also Published As

Publication number Publication date
JPH01501791A (en) 1989-06-22
EP0290442A1 (en) 1988-11-17
EP0290442A4 (en) 1990-07-03
WO1988003805A1 (en) 1988-06-02

Similar Documents

Publication Publication Date Title
AU6866291A (en) Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts
GB2200109B (en) New pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
ZA878953B (en) New pharmacologically active compounds,methods for the preparation thereof and compositions containing the same
AU586182B2 (en) Analgesic 1,2-Benzisothiazol-3-ylpiperazine derivatives
AU6062590A (en) Pharmaceutically active compounds
AU690443B2 (en) Pharmacologically active CNS compounds
NZ231508A (en) Hydroxamic acid derivatives, pharmaceutical compositions and intermediate compounds
AU7418287A (en) Improved penetrating topical pharmaceutical compositions
AU7939887A (en) Pharmaceutical compositions having antineoplastic activity
AU4424285A (en) Pharmacologically active substituted benzamides
PT86000A (en) Pharmaceutically active compounds
AU1032992A (en) Pharmacologically active substituted oxybenzamides
NZ217123A (en) 7-alpha-cephalosporins, pharmaceutical compositions and intermediate compounds
AU8146587A (en) New benzothiadiazine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
AU574806B2 (en) 2,2,6,6 - tetramethyl - 4 - piperidinyl derivatives
AU4581089A (en) N-substituted 2-cyano-3-oxo-3-substituted-proprionamides as anti-inflammatory agents
IT8521235A0 (en) PHARMACOLOGICALLY ACTIVE COMPOUNDS.
GB8622090D0 (en) Pharmacologically active compounds
AU6779487A (en) Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts
KR890700028A (en) Pharmaceutically active compounds and mixtures thereof, organic compositions and metal salts
NZ219949A (en) Cyanoacetamido derivatives having fungicidal activity, fungicidal compositions and intermediate compounds
ZA907398B (en) Pharmacologically active compound,preparation and use
GB8616741D0 (en) Pharmacologically active compounds
AU7748387A (en) Topical iodophor compositions
AU4734185A (en) Quinolizinone compound, processes for preparation thereof and pharmaceutical composition comprising the same